Therapies26 September 2025· 15 min read
Huntington's disease in the AI era evaluates cure claims and regulatory reality in 2025
Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po
By Dr. Eleanor Vance, Regulatory Affairs Editor
Therapies19 September 2025· 14 min read
Testosterone replacement therapy in the UK 2025 evidence based guidance for healthcare professionals
Testosterone replacement therapy is widely requested, yet appropriate use depends on accurate diagnosis. True androgen deficiency is a clinical and biochemical syndrome. Symptoms must align with repea
By Tom Okafor, Clinical Trials Correspondent